Clinical Scorecard: Exploiting VISTA for Immunomodulatory Approaches in Sepsis: Mechanisms and Therapeutic Opportunities
At a Glance
Category
Detail
Condition
Sepsis
Key Mechanisms
Aberrant activation and dysregulation of the host immune system, with VISTA playing a pivotal role in modulating inflammatory responses and immunosuppression.
Target Population
Patients with sepsis and septic shock.
Care Setting
Critical care medicine.
Key Highlights
Sepsis is characterized by acute organ dysfunction due to a dysregulated host response to infection.
VISTA has dual functions as a receptor and ligand, influencing both hyperinflammatory and immunosuppressive phases of sepsis.
Precision immunomodulatory strategies targeting VISTA show promise as novel therapeutic approaches.
Guideline-Based Recommendations
Diagnosis
Sepsis is defined by acute organ dysfunction caused by a dysregulated host response to infection.
Management
Standard care includes early recognition, timely antimicrobial therapy, goal-directed fluid resuscitation, and organ support.
Monitoring & Follow-up
Dynamic assessment of immune status is crucial due to the heterogeneity of immune responses in sepsis.
Risks
Failure of anti-inflammatory strategies targeting single pro-inflammatory mediators has been noted in large-scale trials.
Patient & Prescribing Data
Patients with sepsis experiencing hyperinflammatory and immunosuppressive phases.
VISTA-targeted interventions may improve survival outcomes and immune cell function.
Clinical Best Practices
Implement precision medicine approaches based on immune phenotype and pathogen burden.
Consider the temporal and spatial heterogeneity of immune responses in sepsis management.
